SNRPCP8

Across TCGA pan-cancer cohorts, SNRPCP8 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SNRPCP8’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where SNRPCP8 RNA is repressed in tumor relative to normal tissue. In most cancer types SNRPCP8 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

KIRP, LUAD, and PRAD are the cancer types where SNRPCP8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	IV	−0.242	.042	2	view →
LUAD	Female	All	+0.104	.027	2	view →
PRAD	All	All	+0.042	.032	2	view →
KIRC	All	IV	−0.052	.036	1	view →
BRCA	All	II,III,IV	+0.047	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SNRPCP8–KIRP

Open the KIRP breakdown →